{
    "Title": "In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera",
    "URL": "https://doi.org/10.1371/journal.pntd.0009636",
    "Published": "July 26, 2021",
    "Subject_Areas": [
        "Mycobacterium ulcerans",
        "Nontuberculous mycobacteria",
        "Mycobacterium tuberculosis",
        "Antibiotics",
        "Opportunistic infections",
        "Single nucleotide polymorphisms",
        "Mycobacterium avium complex",
        "Prosthetic device infections"
    ],
    "Authors": {
        "Sacha J. Pidot": [
            "Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Melbourne, Australia"
        ],
        "Jessica L. Porter": [
            "Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Melbourne, Australia"
        ],
        "Troy Lister": [
            "Spero Therapeutics, Cambridge, Massachusetts, United States of America"
        ],
        "Timothy P. Stinear": [
            "Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Melbourne, Australia"
        ]
    }
}